- Postecoglou urges inconsistent Spurs to change perceptions
- UN force says 'widespread destruction' in south Lebanon
- New Zealand on America's Cup cusp after double triumph
- New Zealand's Ravindra makes father proud with 'special' Test ton
- Stock markets mixed as investors weigh earnings, China GDP
- Ten Hag slams 'fairy tales and lies' as Man Utd boss comes out fighting
- Hamas mourns Sinwar, vows no hostage release until war ends
- Forest boss Nuno hit with three-game ban
- 'The killings continue': Sinwar death brings no respite for Gazans
- Gaza 'hell on Earth' for one million children: UN
- Maresca 'very happy' with start of Chelsea career
- New Zealand extends America's Cup lead on Britain
- England boss Tuchel deserves unconditional support: Guardiola
- P&G profits dip, says China recovery will take time
- India fight back after Ravindra ton cements New Zealand lead
- US regulator probes Tesla's self-driving mode after crashes
- Four-month-old baby dies as migrant boat sinks off France
- Kenya parliament backs Ruto's nominated new deputy
- Israel strikes Gaza after killing Hamas chief Sinwar
- Mbappe 'seems unaffected' by rape investigation reports: Ancelotti
- N Korea sending 'large-scale' troop deployment to Russia, Seoul spy agency says
- Global stock markets rise on China hopes
- Lebanon slams 'blatant interference' over remarks attributed to Iran official
- Odegaard nearing Arsenal return, says Arteta
- Women priests secretly ordained in the shadow of the Vatican
- Stellantis workers march in Italy over production slump
- Win over England a 'relief' but doesn't fix Pakistan woes, says Masood
- Howe says he was not contacted by FA over England job
- Biden in Berlin vows no let-up on support for Ukraine
- Meta unveils AI tie-up with horror movie producers
- King Charles arrives in Australia for landmark tour
- Stokes sorry for frustration over dropped catches in England loss
- Baby dies, 65 rescued as migrant boat sinks off France
- Slot warns against snap judgements as Liverpool brace for tough week
- Angry Macron blasts media over reporting of Israel comments
- Ukraine's army brigades battle to make enlisting 'sexy'
- India start steadily after Ravindra ton steers New Zealand to lead of 356
- Ravindra's 134 puts New Zealand in command of India Test
- Kenya's Ruto nominates new deputy after impeachment
- Israel conducts raids on Gaza after killing Hamas chief Sinwar
- Asian markets rise as China economy tops forecasts, gold hits record
- Pakistan crush England in second Test to set up series decider
- Harris, Trump to rally voters in key state on same day
- US sees new chance to end Gaza war with Sinwar killing
- From Siberia to the Sahara: Huskies conquer Mauritania
- Ravindra hits ton to extend New Zealand lead to 299 in India Test
- Marc Marquez quickest in Australian MotoGP practice
- 'Like Texas': Spain's arid south draws Western film shoots
- With record production, Moldova plum farmers hail EU integration
- Nigerians sacrifice cars as cost of living crisis worsens
Pfizer's 2021 profits doubled to $22 bn on strong Covid vaccine sales
Pfizer said Tuesday it expects $32 billion in revenue from Covid-19 vaccines in 2022 as it reported annual profits had more than doubled to $22 billion.
The pharmaceutical giant, which with German company BioNTech won approval for the first vaccine to counter the deadly virus, saw annual revenues nearly double to $81.3 billion, with $36.8 billion from the Covid-19 vaccine.
Pfizer also expects $22 billion in sales of Paxlovid, the company's pill for Covid-19, in 2022.
The results are the latest to show how the coronavirus has transformed Pfizer, which a year ago had projected just $15 billion in Covid-19 vaccines sales in 2021 and ended up selling more than twice that amount after repeatedly lifting the forecast.
Pfizer's scientists "continue to monitor the Covid-19 virus and believe it is unlikely that it will be fully eradicated in the foreseeable future," Chief Executive Albert Bourla said in a statement.
"That said, we now have the tools -- in the forms of vaccines and treatments -- that we believe will help enable us to not only better manage the pandemic but also help countries move into the endemic phase," Bourla said.
"In other words, we believe these tools will help allow us to go back to normality and spend time with family and friends, travel, attend indoor dining and concerts, and enjoy many other activities while lowering the risk of overburdening hospitals and healthcare systems around the world."
Although Pfizer's profit per share topped analyst expectations, revenues fell short.
Shares fell 4.1 percent to $51.02 in pre-market trading.
I.Meyer--BTB